Tuesday May 14
Medivation, Inc. Names Senior Vice President of New Projects
Medivation, Inc. today announced that Stephen M. Kelsey, M.D., F.R.C.P., F.R.C.Path. will join Medivation in the newly-created position of senior vice president of new projects, reporting to Dr.
Mon May 13, 2013
Medivation Downgraded by TheStreet to Sell
The analysts wrote, "Medivation has been downgraded by TheStreet Ratings from hold to sell.
Sat May 11, 2013
Medivation Coverage Initiated at Goldman Sachs
The firm set a "buy" rating on the stock. The analysts wrote, "Medivation is scheduled to report Q1:13 earnings after market close today.
Fri May 10, 2013
Medivation, Inc. Reports First Quarter Financial Results and Provides Corporate Update
Medivation, Inc. today provided a corporate update and reported its financial results for the first quarter ended March 31, 2013.
Thu May 09, 2013
Medivation Management Discusses Q1 2013 Results - Earnings Call Transcript
Good afternoon, everyone, and welcome to Medivation's First Quarter 2013 Financial Results Conference Call.
Dendreon Corporation (DNDN) Searching For A Rebound
"We believe that the fourth quarter may be our strongest quarter of the year," said John Johnson, Dendreon Corporation 's chairman, CEO, and president.
's Top Initiations
Analysts at Benchmark initiated coverage on shares of Merit Medical Systems with a "hold" rating.
Wed May 08, 2013
Medivation Given New $60.00 Price Target at JMP Securities
Several other analysts have also recently commented on the stock. Analysts at Goldman Sachs initiated coverage on shares of Medivation in a research note to investors on Tuesday.
StockCall Pre-Market Review on DNDN, SRPT, ACAD, CTIC, and MDVN
StockCall.com Provides Stock Research on Dendreon Corp., Sarepta Therapeutics Inc., ACADIA Pharmaceuticals Inc., Cell Therapeutics Inc., and Medivation Inc.
Tue May 07, 2013
Medivation, Inc. Announces Participation at Upcoming Investor Conferences
David Hung, M.D., president and chief executive officer, will present at the UBS Global Healthcare Conference on May 20 at 1pm ET at the Grand Hyatt in New York, NY.
Tue Apr 30, 2013
Medivation, Inc. Elects to Board of Directors
Medivation, Inc. today announced that Wendy Yarno has been elected to the Company's Board of Directors.
Positive CHMP Opinion For Xtandia (Enzalutamide) In Advanced Prostate Cancer
Enzalutamide recommended for approval in the European Union for the treatment of adult men with metastatic castration-resistant prostate cancer whose disease has progressed on or after docetaxel therapy 1 Astellas Pharma Europe Ltd., the European Headquarters of Tokyo-based Astellas Pharma Inc.
Sat Apr 27, 2013
Avanir Pharmaceuticals, Inc. (AVNR), Medivation Inc (MDVN) & This Week In Biotech
With the SPDR S&P Biotech Index up 31% over the trailing-12-month period, it's evident that investment dollars are willingly flowing into the biotech sector.
Fri Apr 26, 2013
Astellas Pharma Inc., Medivation, Inc. Release: Positive Opinion for...
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today! CHERTSEY, England & SAN FRANCISCO, CA-- --Today, Astellas Pharma Europe Ltd., the European Headquarters of Tokyo-based Astellas Pharma Inc.
Hedge Funds Are Buying These 2 Biotech Stocks
One of the best ways that investors can try to decide which stocks will make for a good investment is to look at what the pros are doing.
Thu Apr 25, 2013
Medivation Announces First Quarter 2013 Financial Results Teleconference on May 9, 2013
Medivation, Inc. today announced that it will host a live teleconference with management to discuss first quarter 2013 financial results and provide a general business update on May 9, 2013 at 4:30 p.m. Eastern Time.